ARMISTICE CAPITAL, LLC sold 83.4% of their position (3.68M shares) of AVALO THERAPEUTICS, INC. on the open market
Open‑market sale worth $2.17M — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 6/28/2023ACC: 0000899243-23-016659
Director10% Owner
Since Jun 2018
-3.68M
Net shares
Net seller
$2.17M
Total sold
2
Open market trades
0B · 2S
2
Total transactions
3.68M disposed
Non-Derivative Transactions2
Common Stock
Indirect
Shares
−2.75M
Price / share
$0.61
Trade value
$1.68M
% of position
62.2%
6/26/2023
4.42M→1.67M
Common Stock
Indirect
Shares
−937.40K
Price / share
$0.52
Trade value
$486.89K
% of position
56.2%
6/27/2023
1.67M→731.46K
Total
Net shares
−3.68M
Net value
-$2.17M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 6/26/2023 | S · Sale | −2.75M | $0.61 | $1.68M | 62.2% | 4.42M | 1.67M |
| Common Stock Indirect | 6/27/2023 | S · Sale | −937.40K | $0.52 | $486.89K | 56.2% | 1.67M | 731.46K |
| Total | −3.68M | -$2.17M | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
DirectShares owned34.37K
Total
34.37K direct34.37K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 34.37K | Direct |
| Total | 34.37K | 34.37K direct |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported